Jazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion

Related Link: 

Jazz Pharmaceuticals is nearing a deal to buy Celator Pharmaceuticals for about $1.5 billion, a huge premium for a company with a promising leukemia drug but no revenue.

Few Spinoffs Make a Clean Break

Related Link: 

The spate of spinoffs from companies such as Hewlett Packard Enterprise and Baxter International often masks the complex challenges finance chiefs face in the aftermath.

Solar Panel Leasing Decreases, as More Customers Look to Buy

Related Link: 

Companies such as SolarCity and Sunrun rapidly expanded by leasing solar panels to homeowners but now face stiff competition from smaller upstarts that sell the units to customers instead.

'X-Men' Sequel Rises to the Top

Related Link: 

Two Hollywood franchises turned in disappointing box-office performances on Memorial Day weekend. “Alice Through The Looking Glass” flopped, while the superhero sequel “X-Men: Apocalypse” opened to $80 million.

The Price 'Assertive' Women Pay At Work---and How to Minimize It

Related Link: 

Research shows women on average are penalized for direct, explicit forms of assertiveness but not for assertiveness expressed through nonverbal means.

J.P. Morgan's Security Game Plan

Related Link: 

CIO Dana Deasy discusses the bank’s strategy since the 2014 breach, as well as working with fintech partners.

Air France-KLM Discusses Selling Stake in Catering Unit to China's HNA

Related Link: 

Air France-KLM said it is in exclusive talks to sell a 49.99% stake in its airline catering unit, Servair, to China’s HNA Group.

Verizon Workers Win Concessions in Deal to End Strike

Related Link: 

Two unions representing more than 36,000 Verizon workers were able to win concessions from the carrier in a new four-year contract, helping to end a nearly seven-week labor strike.

Forecast for Workday's Stock: Cloudy

Related Link: 

Workday has a track record of beating analyst estimates, but that doesn’t mean its shares will respond accordingly.

Rum Makers in Spirited Battle

Related Link: 

The prospect of a U.S. market return for a Cuban spirit is inflaming a decades-old battle pitting Pernod Ricard, the world’s second-largest spirits producer, against Bacardi, the dominant U.S. seller of rum.

Syndicate content